Latest Insider Transactions at Alignment Healthcare, Inc. (ALHC)
This section provides a real-time view of insider transactions for Alignment Healthcare, Inc. (ALHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alignment Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alignment Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 04
2023
|
Hyong Kim Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
340,136
+45.82%
|
-
|
|
Sep 14
2023
|
Joseph S Konowiecki Director |
BUY
Grant, award, or other acquisition
|
Direct |
174,216
+12.74%
|
-
|
|
Sep 13
2023
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
15,474
-5.46%
|
$77,370
$5.2 P/Share
|
|
Sep 06
2023
|
Christopher J Joyce Chief Legal and Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
283,308
+50.0%
|
-
|
|
Jul 05
2023
|
Melinda Michele Kimbro Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
175,439
+50.0%
|
-
|
|
May 09
2023
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
5,300
-0.28%
|
-
|
|
May 08
2023
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
65,000
-3.37%
|
-
|
|
Mar 31
2023
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,290
-0.46%
|
$19,740
$6.26 P/Share
|
|
Mar 29
2023
|
Richard A. Cross SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
1,710
-0.43%
|
$10,260
$6.11 P/Share
|
|
Mar 29
2023
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,506
-1.45%
|
$207,036
$6.11 P/Share
|
|
Mar 29
2023
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
7,178
-0.37%
|
$43,068
$6.11 P/Share
|
|
Mar 29
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
3,286
-0.3%
|
$19,716
$6.11 P/Share
|
|
Mar 29
2023
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,312
-0.74%
|
$31,872
$6.11 P/Share
|
|
Mar 14
2023
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
2,400
-0.12%
|
-
|
|
Mar 14
2023
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
20,006
-1.02%
|
$120,036
$6.33 P/Share
|
|
Mar 14
2023
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
39,101
-1.62%
|
$234,606
$6.33 P/Share
|
|
Mar 14
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
14,164
-1.28%
|
$84,984
$6.33 P/Share
|
|
Mar 14
2023
|
Richard A. Cross SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
5,516
-1.38%
|
$33,096
$6.33 P/Share
|
|
Mar 14
2023
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,470
-1.84%
|
$80,820
$6.33 P/Share
|
|
Mar 09
2023
|
Joseph S Konowiecki Director |
BUY
Open market or private purchase
|
Direct |
100,000
+8.94%
|
$600,000
$6.62 P/Share
|
|
Mar 08
2023
|
Thomas J. Carella Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,070
+25.6%
|
-
|
|
Mar 08
2023
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,070
+10.86%
|
-
|
|
Mar 08
2023
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+6.47%
|
-
|
|
Mar 08
2023
|
Nicholas Robbert Vorhoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,337
+29.77%
|
-
|
|
Mar 08
2023
|
Jeffrey H Margolis Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+22.65%
|
-
|
|
Mar 08
2023
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+20.78%
|
-
|
|
Mar 08
2023
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,070
+33.49%
|
-
|
|
Mar 08
2023
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,802
+30.16%
|
-
|
|
Mar 08
2023
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,337
+29.77%
|
-
|
|
Mar 02
2023
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
6,800
-0.35%
|
-
|
|
Feb 01
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.9%
|
$120,000
$12.19 P/Share
|
|
Jan 18
2023
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,100
-0.21%
|
$14,300
$13.01 P/Share
|
|
Jan 18
2023
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
1,100
-0.04%
|
$14,300
$13.01 P/Share
|
|
Jan 18
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
1,125
-0.1%
|
$14,625
$13.01 P/Share
|
|
Jan 17
2023
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
5,000
-0.25%
|
$60,000
$12.54 P/Share
|
|
Jan 13
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.8%
|
$108,000
$12.09 P/Share
|
|
Jan 03
2023
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.09%
|
$12,000
$12.01 P/Share
|
|
Dec 21
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
4,274
-0.22%
|
$51,288
$12.01 P/Share
|
|
Dec 15
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
726
-0.04%
|
$8,712
$12.02 P/Share
|
|
Dec 01
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.91%
|
$325,000
$13.11 P/Share
|
|
Dec 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-4.41%
|
$312,000
$13.1 P/Share
|
|
Dec 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.74%
|
$260,000
$13.08 P/Share
|
|
Nov 10
2022
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
5,000
-0.25%
|
-
|
|
Nov 07
2022
|
Joseph S Konowiecki Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,906
+5.54%
|
-
|
|
Nov 07
2022
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,429
+2.28%
|
-
|
|
Nov 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-2.55%
|
$390,000
$13.39 P/Share
|
|
Nov 01
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.9%
|
$325,000
$13.23 P/Share
|
|
Nov 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-4.22%
|
$312,000
$13.23 P/Share
|
|
Oct 26
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-0.89%
|
$325,000
$13.07 P/Share
|
|
Oct 26
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-4.05%
|
$312,000
$13.08 P/Share
|